港股異動 | 沛嘉醫療-B(9996.HK)放量彈升近10% 日前曾創下上市以來新低
格隆匯12月2日丨沛嘉醫療-B(9996.HK)放量拉昇至9.71%,報22.6港元,暫成交9424萬港元,總市值143億港元。近期股價持續走低,日前曾創下上市以來新低價19.96港元。香港股票分析師協會副主席郭思治日前稱,沛嘉醫療最近導管更換主動脈瓣研發產品有新進展,TaurusOne已完成臨牀試驗並遞交註冊申請,至於TaurusElite完成臨牀全部病人入組,預計近期也會遞交註冊申請。從近期富達增持及大行給予目標價33.6港元,可見公司研發進度及前景可期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.